Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes
β Scribed by Turnley, Ann M.; Morahan, Grant; Okano, Hideyuki; Bernard, Ora; Mikoshiba, Katsuhiko; Allison, Janette; Bartlett, Perry F.; Miller, J. F. A. P.
- Book ID
- 109778517
- Publisher
- Nature Publishing Group
- Year
- 1991
- Tongue
- English
- Weight
- 570 KB
- Volume
- 353
- Category
- Article
- ISSN
- 0028-0836
- DOI
- 10.1038/353566a0
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Transgenic mice carrying the HER-2/neu proto-oncogene under tissue-specific transcriptional control of a mammary tumor virus long terminal repeat (Tg-MMTVneu mice) spontaneously develop mammary carcinomas. HER-2/neu is a tumor antigen that can be recognized by cytotoxic T lymphocytes if tumor cells
Mechanisms of major histocompatibility complex (MHC) class I gene regulation in cells of the CNS have been studied in vitro. Astrocytes in primary cultures, but neither oligodendrocytes nor neurons, constitutively expressed cell surface MHC class I molecules. Interferon-gamma (IFN-.I) treatment led
## Abstract Hepatitis C virus (HCV) infection is often persistent, but its mechanism and pathogenesis remain unclear. One mechanism through which HCV escapes systemic immunosurveillance might be via impaired dendritic cells (DCs), which are the most potent type of antigenβpresenting cells. We exami